CAS: 5230-87-5 - (1R,4R,5R,6S,6aR,7R,9R,9aS)-1,5,6a,7-tetrahydroxy-5,9-dimethylhexahydrospiro[4,9a-methanocyclopenta[d]oxocine-6,3'-oxetane]-2,2'(1H)-dione

Formule : C₁₅H₂₀O₈

InChI : InChI=1S/C15H20O8/c1-6-3-7(16)15(21)13(6)4-8(23-10(18)9(13)17)12(2,20)14(15)5-22-11(14)19/h6-9,16-17,20-21H,3-5H2,1-2H3/t6-,7-,8?,9+,12+,13+,14+,15-/m1/s1

Code InChI : InChIKey=GEVWHIDSUOMVRI-QHRGTXDDSA-N

SMILES : O=C1OC2CC3(C1O)C(C)CC(O)C3(O)C4(C(=O)OC4)C2(O)C

Synonymes :

• (-)-Anisatin
• (1R,3′S,4R,5R,6aR,7R,9R,9aS)-Hexahydro-1,5,6a,7-tetrahydroxy-5,9-dimethylspiro[4H-4,9a-methanocyclopent[d]oxocin-6(2H),3′-oxetane]-2,2′-dione
• (1S,2R,4R,5R,6S,7R,8R,11R)-4,5,7,11-Tetrahydroxy-2,7-dimethyl-10H-spiro[9-oxatricyclo[6.3.1.0~1,5~]dodecane-6,3'-oxetane]-2',10-dione
• Spiro[4H-4,9a-methanocyclopent[d]oxocin-6(2H),3′-oxetane]-2,2′-dione, hexahydro-1,5,6a,7-tetrahydroxy-5,9-dimethyl-, (1R,3′S,4R,5R,6aR,7R,9R,9aS)-
• Spiro[6H-4,9a-methanocyclopent[d]oxocin-6,3′-oxetane]-2,2′(1H)-dione, 4aβ,5,6a,7,8,9-hexahydro-1α,5β,6aβ,7β-tetrahydroxy-5,9α-dimethyl-
• Spiro[6H-4,9a-methanocyclopent[d]oxocin-6,3′-oxetane]-2,2′(1H)-dione, hexahydro-1,5,6a,7-tetrahydroxy-5,9-dimethyl-, (1R,3′S,4R,5R,6aR,7R,9R,9aS)-
• Spiro[6H-4,9a-methanocyclopent[d]oxocin-6,3′-oxetane]-2,2′(1H)-dione, hexahydro-1,5,6a,7-tetrahydroxy-5,9-dimethyl-, [1R-(1α,4β,5β,6β,6aβ,7β,9α,9aβ)]-

Anisatin

CAS : 5230-87-5

• Formule : C₁₅H₂₀O₈
• Degré de pureté : 95%~99%
• Masse moléculaire : 328.317

Anisatin

CAS : 5230-87-5

Lactone

• Formule : C₁₅H₂₀O₈
• Degré de pureté : ≥ 95.0 % (HPLC)
• Couleur et forme : Powder
• Masse moléculaire : 328.32

Anisatin

CAS : 5230-87-5

Anisatin is a potent kinase inhibitor that has been shown to have anticancer properties. It …

• Formule : C₁₅H₂₀O₈
• Degré de pureté : Min. 95%
• Masse moléculaire : 328.31 g/mol